Kurt Kimpinski

Kurt Kimpinski

Auto-generated profile, based on publicly available information

Kurt Kimpinski

School of Kinesiology, Western University, London, Ontario, Canada; Department of Clinical Neurological Sciences, University Hospital, London Health Sciences Centre, London, Ontario, Canada; Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2009 in Archives of Neurology
Verified
Journal Article
Open access
PDF file
ALAxel Lipp
Axel Lipp
PSPaola Sandroni
Paola Sandroni
JAJ. Eric Ahlskog
J. Eric Ahlskog
RFRobert D. Fealey
Robert D. Fealey
KKKurt Kimpinski
Kurt Kimpinski
PLPhillip A. Low
Phillip A. Low
Multiple system atrophy (MSA) is a sporadic multisystem progressive disorder characterized by autonomic failure, with orthostatic hypotension (OH), neurogenic bladder and erectile dysfunction, cerebellar ataxia, corticospinal dysfunction, and parkinsonism that may be poorly responsive to levodopa.1,2 A major clinical dilemma is whether a patient with parkinsonism has Parkinson disease (PD) or MSA, as the prognosis of MSA is much worse. Autonomic involvement is common in PD but is more variable in severity than MSA.3-5 Mild OH is relatively common in PD and occasionally severe OH can occur.6,7 In retrospective studies from the Mayo Clinic, we reported that, when quantitative methods were used, the severity and distribution of autonomic deficits appear to distinguish MSA from PD.4,5 In contrast to MSA, which is predominantly a preganglionic disorder, autonomic pathology in PD is primarily postganglionic,8 which can be explored in autonomic function tests. Postganglionic adrenergic neuropathy forms the basis of neuroimaging studies of the postganglionic axons of the heart with iodine-123 metaiodobenzylguanidine or other postganglionic adrenergic markers suitable for positron-emission tomography, whereas uptake is markedly reduced or absent in PD and usually normal in MSA.9-13

30 March 2018 in Clinical and Experimental Pharmacology and Physiology
Verified
Journal Article
Open access
PDF file
JBJacquie Baker
Jacquie Baker
KKKurt Kimpinski
Kurt Kimpinski
Summary: Cardiovascular diseases account for approximately one‐third of all deaths each year. Of this, hypertension accounts for approximately 9.4 million deaths. Melatonin, the primary circadian hormone, has been substantiated as an effective and safe adjunct anti‐hypertensive agent. In support of this, melatonin receptors have been identified within the central and peripheral nervous system, as well as the cardiovascular system, including various vascular tissues. Therefore, it is not surprising that recent research has emerged highlighting a key role of melatonin in autonomic regulation of blood pressure. In animals, pinealectomies elicit peripheral vasoconstriction and hypertension. In studies involving humans, both healthy controls and patient populations of essential and nocturnal hypertension, melatonin administration demonstrates significant hypotensive effects that yield clinically significant results. However, the precise mechanism by which melatonin elicits its hypotensive effects in humans require further investigation. This review focuses on melatonin, its role within the cardiovascular system and the emerging implications for its use as an anti‐hypertensive agent. Additionally, this review will discuss the current thinking on potential mechanisms behind the hypotensive effects of melatonin including: endothelium‐dependent vasodilation, anti‐oxidant defence mechanisms and sympatho‐vagal autonomic regulation.


6 January 2012 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Closed access
PDF file
VIValeria Iodice
Valeria Iodice
ALAxel Lipp
Axel Lipp
JAJ Eric Ahlskog
J Eric Ahlskog
PSPaola Sandroni
Paola Sandroni
RFRobert D Fealey
Robert D Fealey
PLPhillip A Low
Phillip A Low
Background Multiple system atrophy (MSA) is a sporadic progressive neurodegenerative disorder characterised by autonomic failure, manifested as orthostatic hypotension or urogenital dysfunction, with combinations of parkinsonism that is poorly responsive to levodopa, cerebellar ataxia and corticospinal dysfunction. Published autopsy confirmed cases have provided reasonable neurological characterisation but have lacked adequate autonomic function testing. Objectives To retrospectively evaluate if the autonomic characterisation of MSA is accurate in autopsy confirmed MSA and if consensus criteria are validated by autopsy confirmation. Methods 29 autopsy confirmed cases of MSA evaluated at the Mayo Clinic who had undergone formalised autonomic testing, including adrenergic, sudomotor and cardiovagal functions and Thermoregulatory Sweat Test (TST), from which the Composite Autonomic Severity Score (CASS) was derived, were included in the study. Results Patient characteristics: 17 men, 12 women; age of onset 57±8.1 years; disease duration to death 6.5±3.3 years; first symptom autonomic in 18, parkinsonism in seven and cerebellar in two. Clinical phenotype at first visit was MSA-P (predominant parkinsonism) in 18, MSA-C (predominant cerebellar involvement) in eight, pure autonomic failure in two and Parkinson's disease in one. Clinical diagnosis at last visit was MSA for 28 cases. Autonomic failure was severe: CASS was 7.2±2.3 (maximum 10). TST% was 65.6±33.9% and exceeded 30% in 82% of patients. The most common pattern was global anhidrosis. Norepinephrine was normal supine (203.6±112.7) but orthostatic increment of 33.5±23.2% was reduced. Four clinical features (rapid progression, early postural instability, poor levodopa responsiveness and symmetric involvement) were common. Conclusion The pattern of severe and progressive generalised autonomic failure with severe adrenergic and sudomotor failure combined with the clinical phenotype is highly predictive of MSA.


9 February 2017 in Muscle & Nerve
Verified
Journal Article
Closed access
PDF file
JRJuan M. Racosta
Juan M. Racosta
LSLuciano A. Sposato
Luciano A. Sposato
KKKurt Kimpinski
Kurt Kimpinski